We have used our human tissue model of early lung fibrosis to perform the first detailed analysis of the anti-fibrotic effects of pirfenidone and nintedanib in human lung tissue stimulated with the key pro-fibrotic growth factor TGFβ1. The gene discussed is TGFB1; the disease is pulmonary fibrosis.